Study validates long-term safety and efficacy of Harmony transcatheter pulmonary valve implant

A study of one year outcomes in the largest cohort to date of Harmony transcatheter pulmonary valve (TPV) patients with congenital heart disease (CHD) and severe pulmonary regurgitation (PR) was presented today as late-breaking clinical research at the Society for Cardiovascular Angiography & Interventions 2022 Scientific Sessions.

Related Keywords

Los Angeles ,Daniels Levi ,Emily Henderson ,Society For Cardiovascular Angiography Interventions ,Clinical Events Committee ,Cardiovascular Angiography ,Continued Access ,Clinical Events ,Mattel Children ,Efficacy ,Angiography ,Children ,Congenital Heart Disease ,Heart ,Heart Disease ,Heart Surgery ,Research ,Estenosis ,Surgery ,